Wilfong Diane E. 4
4 · GILEAD SCIENCES, INC. · Filed Feb 7, 2023
Insider Transaction Report
Form 4
Wilfong Diane E
Interim Corp Controller & CAO
Transactions
- Exercise/Conversion
Common Stock
2023-02-06+1,864→ 32,575 total - Tax Payment
Common Stock
2023-02-06$86.36/sh−565$48,793→ 32,010 total - Exercise/Conversion
Restricted Stock Unit
2023-02-06−1,864→ 11,060 total→ Common Stock (1,864 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
- [F2]The restricted stock units have a four-year vesting schedule. 25% vest on the yearly anniversary of the date of grant until fully vested.